Congenital Heart Disease in Pregnancy, Fetal Echocardiography, Prenatal Diagnosis
Conditions
Keywords
Congenital Heart Disease, Prenatal diagnosis, Fetal Echocardiography, Maternal-fetal medicine, Digital health technologies
Brief summary
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling of congenital heart disease in medical institutions in China, in order to understand the current status and existing problems of prenatal prevention and treatment capacity of congenital heart disease in China, and to obtain corresponding baseline data, so as to provide scientific basis for further improving prenatal screening and diagnosis policies in China.
Detailed description
With the rapid development of medical imaging technology, the role of ultrasound screening and diagnosis in the prevention and treatment of birth defects is increasingly prominent. Early screening, classified diagnosis, and standardized consultation are the basis for effective prevention and treatment of congenital heart disease. Due to the uneven development of medical resources and medical service levels in the eastern, central, and western regions of China, as well as between urban and rural areas, the ability of prenatal ultrasound screening, diagnosis, and clinical consultation varies greatly, and there is a lack of relevant clinical research data, which makes it difficult to adopt effective intervention measures. This study aims to investigate and analyze the prenatal screening, diagnosis, and consultation abilities of medical personnel in different regions, evaluate the current status and problems of congenital heart disease abilities in various regions, explore a multidisciplinary transfer consultation integrated service mechanism, strengthen comprehensive prevention and control abilities, ensure maternal and infant health.
Interventions
To investigate and evaluate the capacity of prenatal screening, diagnosis and counseling for fetal heart disease based on medical institutions; Improving capacity for prenatal screening, diagnosis and counselling through integrated products embedded with new technologies.
Sponsors
Study design
Eligibility
Inclusion criteria
* All pregnant women and fetuses who underwent prenatal ultrasound examination in the above hospitals were enrolled
Exclusion criteria
* Pregnant women not willing to cooperate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The integrity rate of the multi-view acquisition | From June 2023 to Oct 2023 | The integrity rate of the multi-view acquisition |
| Negative coincidence rate congenital heart disease screening | From June 2023 to Oct 2023 | Negative coincidence rate congenital heart disease screening |
| Positive coincidence rate of congenital heart disease screening | From June 2023 to Oct 2023 | Positive coincidence rate of congenital heart disease screening |
| The coincidence rate of multidisciplinary consultation | From June 2023 to Oct 2023 | The coincidence rate of multidisciplinary consultation |